DnB Asset Management AS purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 14,447 shares of the biotechnology company’s stock, valued at approximately $3,248,000.
A number of other large investors also recently modified their holdings of the business. AE Wealth Management LLC increased its holdings in shares of Axon Enterprise by 3.9% during the first quarter. AE Wealth Management LLC now owns 1,418 shares of the biotechnology company’s stock valued at $319,000 after purchasing an additional 53 shares during the period. PNC Financial Services Group Inc. increased its holdings in shares of Axon Enterprise by 1.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 4,340 shares of the biotechnology company’s stock valued at $720,000 after purchasing an additional 58 shares during the period. Oak Ridge Investments LLC increased its holdings in shares of Axon Enterprise by 0.6% during the first quarter. Oak Ridge Investments LLC now owns 10,484 shares of the biotechnology company’s stock valued at $2,357,000 after purchasing an additional 61 shares during the period. Advisor Partners II LLC increased its holdings in shares of Axon Enterprise by 2.6% during the fourth quarter. Advisor Partners II LLC now owns 2,632 shares of the biotechnology company’s stock valued at $437,000 after purchasing an additional 66 shares during the period. Finally, Beese Fulmer Investment Management Inc. boosted its stake in Axon Enterprise by 1.9% during the fourth quarter. Beese Fulmer Investment Management Inc. now owns 3,860 shares of the biotechnology company’s stock valued at $640,000 after buying an additional 72 shares in the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Axon Enterprise news, CFO Brittany Bagley acquired 250 shares of the firm’s stock in a transaction on Wednesday, May 17th. The stock was purchased at an average cost of $200.00 per share, for a total transaction of $50,000.00. Following the transaction, the chief financial officer now owns 109,174 shares of the company’s stock, valued at approximately $21,834,800. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Axon Enterprise news, CFO Brittany Bagley acquired 250 shares of the firm’s stock in a transaction on Wednesday, May 17th. The stock was purchased at an average cost of $200.00 per share, for a total transaction of $50,000.00. Following the transaction, the chief financial officer now owns 109,174 shares of the company’s stock, valued at approximately $21,834,800. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Hadi Partovi acquired 10,000 shares of the firm’s stock in a transaction on Wednesday, May 17th. The shares were acquired at an average price of $200.02 per share, with a total value of $2,000,200.00. Following the completion of the transaction, the director now directly owns 378,817 shares in the company, valued at approximately $75,770,976.34. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 45,250 shares of company stock worth $8,735,200 and sold 54,458 shares worth $10,534,340. Corporate insiders own 6.10% of the company’s stock.
Axon Enterprise Trading Down 2.5 %
Axon Enterprise (NASDAQ:AXON – Free Report) last released its quarterly earnings results on Tuesday, May 9th. The biotechnology company reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.48. Axon Enterprise had a return on equity of 10.65% and a net margin of 10.76%. The business had revenue of $343.04 million during the quarter, compared to analyst estimates of $312.07 million. Sell-side analysts forecast that Axon Enterprise, Inc. will post 1.58 earnings per share for the current year.
Analyst Upgrades and Downgrades
AXON has been the subject of several research reports. TheStreet cut Axon Enterprise from a “b-” rating to a “c+” rating in a research note on Friday, May 26th. Robert W. Baird raised their target price on Axon Enterprise from $237.00 to $240.00 in a research note on Thursday, May 11th. JMP Securities reaffirmed a “market outperform” rating and set a $235.00 target price on shares of Axon Enterprise in a research note on Friday, April 14th. Credit Suisse Group raised their target price on Axon Enterprise from $300.00 to $309.00 in a research note on Wednesday, May 10th. Finally, JPMorgan Chase & Co. raised Axon Enterprise from a “neutral” rating to an “overweight” rating and set a $236.00 target price for the company in a research note on Thursday, May 11th. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $232.64.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also
- Five stocks we like better than Axon Enterprise
- Order From U.S. Army Fuels Surge In Enovix Stock
- The Bottom Is In For Mullen Automotive
- Could Meta Be Risking Another Sell Off With Its New “Threads”?
- 2 Must-Have Specialized ETFs for the Long-Term Investor
- Inspire Medical Up 15% After Breakout, Analysts Say It’s A Buy
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
